About us

Raphael Chauchard, Founder of HB Aesthetics

Raphael Chauchard, Founder of HB Aesthetics

Founded in 2004 by Raphael Chauchard, a chemist specialized in skincare formulation and aesthetic medicine, HB Aesthetics was built with a singular purpose: to elevate skin health through science, innovation, uncompromising quality, and ultra-selective distribution with professionals.

Raphael’s scientific background — spanning chemistry, process engineering, dermatology, and biochemistry at the University of Montpellier — shaped a philosophy rooted in results, safety, and respect for the skin. After years within leading pharmaceutical laboratories, he set out to create a new generation of skincare treatments, primarily focused on dermatologists, aesthetic medicine doctors, and estheticians.

Our timeline

2004

Company creation. HB Aesthetics is founded by Raphael Chauchard.

2008

Fusion Meso launch. Mesotherapy and sterile cosmetics for micro-needling.

2015

Production internalization. 1,000 sqm factory — offices, clean rooms, filling and conditioning rooms.

2017

Ekseption launch. Natural skin resurfacing and peelings, with skincare based on the properties of organic acids.

2021

Fusion Meso expansion. The assortment grows with specific skincare based on aesthetic medicine ingredients, to manage before- and after-procedure care.

2022

New premium factory. 5,000 sqm, workforce up 50%, revenue nearly doubled since inception. ISO 9001 quality certification obtained.

2023

Opening up to the world. HB Aesthetics opened its capital to a private equity fund, consolidating its presence across all continents.

2025

Acurhyal launch. New medical devices for mesotherapy.

HB Aesthetics

HBA today

  • Present in +70 countries worldwide
  • +20% average annual growth
  • 77 distributors, +6,000 aesthetic clinics, +14,000 beauty centers
  • 9.17/10 average client satisfaction rating

ISO 9001 & GMP certified, in-house manufacturing in Spain

Regional footprint: Europe 37% · Asia Pacific 35% · Middle East & Africa 20% · Americas 8%